Paper19772
Use of DRL in differentiating anxiolytic and neuroleptic properties of CNS drugs.
Canon JG and 1 other. Pharmacol Biochem Behav, 1977. Cited by 46 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Use of DRL in differentiating anxiolytic and neuroleptic properties of CNS drugs. Papers, record 19772. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19772
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Anxiety Agents | Major topic |
| Behavior, Animal | Major topic |
| Psychotropic Drugs | Major topic |
| Reinforcement Schedule | Major topic |
| Tranquilizing Agents | Major topic |
| Animals | |
| Chlorpromazine | |
| Clozapine | |
| Conditioning, Operant | |
| Dextroamphetamine | |
| Diazepam | |
| Drug Evaluation, Preclinical | |
| Male | |
| Rats |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37,488,262 | Interval timing relative to response inhibition in the differential reinforcement of low-rate responding in normally developing young adults. | Sci Rep | 2023 | https://conductscience.org/library/papers/37488262 | PubMed |
| 25,566,001 | Impulsive actions and choices in laboratory animals and humans: effects of high vs. low dopamine states produced by systemic treatments given to neurologically intact subjects. | Front Behav Neurosci | 2014 | https://conductscience.org/library/papers/25566001 | PubMed |
| 8,856,830 | Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokinetics. | Psychopharmacology (Berl) | 1996 | https://conductscience.org/library/papers/8856830 | PubMed |
| 6,771,817 | The effects of caffeine on timing behaviour in rodents: comparisons with chlordiazepoxide. | Psychopharmacology (Berl) | 1980 | https://conductscience.org/library/papers/6771817 | PubMed |
| 3,936,105 | Is delay of reward mediated by shock-avoidance behavior a critical target for anti-punishment effects of diazepam in rats? | Psychopharmacology (Berl) | 1985 | https://conductscience.org/library/papers/3936105 | PubMed |
| 3,931,150 | Comparison between the effects of propranolol and chlordiazepoxide on timing behaviour in the rat. | Psychopharmacology (Berl) | 1985 | https://conductscience.org/library/papers/3931150 | PubMed |
| 2,862,657 | Benzodiazepines reduce the tolerance to reward delay in rats. | Psychopharmacology (Berl) | 1985 | https://conductscience.org/library/papers/2862657 | PubMed |
| 1,377,396 | Impaired acquisition of temporal differentiation performance following lesions of the ascending 5-hydroxytryptaminergic pathways. | Psychopharmacology (Berl) | 1992 | https://conductscience.org/library/papers/1377396 | PubMed |
| 729,736 | Picrotoxin-diazepam interaction in a behavioural schedule of differential reinforcement of low rates. | Experientia | 1978 | https://conductscience.org/library/papers/729736 | PubMed |
| 113,832 | A comparison of clozapine, chlorpromazine, and thioridazine upon DRL performance in the squirrel monkey. | Psychopharmacology (Berl) | 1979 | https://conductscience.org/library/papers/113832 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19772
GET https://conductscience.org/api/papers/v1/19772/authors